Adrenal Cortical Steroidogenic Enzyme Expression is Associated with Hypertension, Obesity and Corticosteroid Use: A Tissue Microarray Study of Human Adrenal Tissue

Abstract

Steroidogenesis in the human adrenal cortex follows a distinct anatomical and functional zonation, which is essential for maintaining electrolyte balance, stress response, and metabolic homeostasis. Dysregulation of this tightly controlled system leads to endocrine disorders causing hypertension, such as primary aldosteronism and glucocorticoid excess. The aim of this study was to analyze the zonal distribution and expression levels of enzymes involved in steroidogenesis and correlate these findings with hypertension, body mass index and previous administration of corticosteroids while correcting severe acute respiratory syndrome coronavirus 2 infection as a potential confounder. Tissue microarrays were constructed from 99 formalin-fixed paraffin-embedded adrenal glands obtained from adult human autopsies, with clinical information on hypertension status. As controls, 14 normal adrenal glands derived from surgical specimens were included. Protein expression of CYP11B2, CYP11B1, CYP17, HSD3B1, and HSD3B2 was assessed semi-quantitatively and evaluated with respect to their localization within specific adrenal cortical zones using immunohistochemistry. The expression of CYP17, CYP11B1, CYP11B2, and HSD3B2 was inversely correlated with the presence of hypertension (p<0.001 and p=0.0149), higher body mass index (p=0.026 and p=0.001), and the administration of corticosteroids (p=0.0012, p=0.001, and p=0.002). CYP11B2 showed reduced expression in the zona glomerulosa only in the non-COVID-19 hypertension group (p=0.031). Tissue microarray-based tissue analysis is a reliable method in a research setting to detect consistent downregulation of CYP11B1, CYP11B2, and CYP17 in patients with hypertension, independent of concomitant underlying infections. The positive correlation between the body mass index and CYP11B1 expression, and the negative correlation between glucocorticoid administration and CYP11B1, may reflect clinical factors such as obesity-associated hypertension and altered aldosterone production and its relationship with metabolic syndrome.

Keywords

adrenal gland - steroidogenic enzyme expression - obesity - immunohistochemistry

Publication History

Received: 12 October 2025

Accepted after revision: 04 November 2025

Article published online:
08 December 2025

• References

• 1 Enberg U, Volpe C, Hamberger B. New aspects on primary aldosteronism. Neurochem Res 2003; 28: 327-332
• 2 Azizan EAB, Drake WM, Brown MJ. Primary aldosteronism: molecular medicine meets public health. Nat Rev Nephrol 2023; 19: 788-806
• 3 Fernandes-Rosa FL, Boulkroun S, Fedlaoui B. et al. New advances in endocrine hypertension: from genes to biomarkers. Kidney Int 2023; 103: 485-500
• 4 Papadopoulou-Marketou N, Vaidya A, Dluhy R, Chrousos GP. Hyperaldosteronism. In: Feingold KR, Ahmed SF, Anawalt B et al., editors. In: Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc. 2000. 2020 Aug 6. PMID: 25905293 Bookshelf ID: NBK279065
• 5 Volpe C, Hamberger B, Hoog A. et al. Primary aldosteronism: functional histopathology and long-term follow-up after unilateral adrenalectomy. Clin Endocrinol 2015; 82: 639-647
• 6 Zennaro MC, Boulkroun S, Fernandes-Rosa FL. Pathogenesis and treatment of primary aldosteronism. Nat Rev Endocrinol 2020; 16: 578-589
• 7 Lim JS, Rainey WE. The potential role of aldosterone-producing cell clusters in adrenal disease. Horm Metab Res 2020; 52: 427-434
• 8 Nanba K, Tsuiki M, Sawai K. et al. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry. J Clin Endocrinol Metab 2013; 98: 1567-1574
• 9 Riemenschnitter C, Teleki I, Tischler V. et al. Stability and prognostic value of Slug, Sox9 and Sox10 expression in breast cancers treated with neoadjuvant chemotherapy. Springerplus 2013; 2: 695
• 10 Verwoert GC, Hofland J, Amin N. et al. Expression and gene variation studies deny association of human HSD3B1 gene with aldosterone production or blood pressure. Am J Hypertens 2015; 28: 113-120
• 11 Arlt W, Lang K, Sitch AJ. et al. Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism. JCI Insight 2017; 2
• 12 Engeli S, Jordan J. Novel metabolic drugs and blood pressure: implications for the treatment of obese hypertensive patients?. Curr Hypertens Rep 2013; 15: 470-474
• 13 Takeda Y, Demura M, Kometani M. et al. Molecular and epigenetic control of aldosterone synthase, CYP11B2 and 11-hydroxylase, CYP11B1. Int J Mol Sci 2023; 24: 5782
• 14 Raff H, Phillips J, Simpson P. et al. Interaction of chronic pain, obesity and time of day on cortisol in female human adolescents. Stress 2022; 25: 331-336
• 15 Mebrahtu TF, Morgan AW, West RM. et al. Oral glucocorticoids and incidence of hypertension in people with chronic inflammatory diseases: a population-based cohort study. CMAJ 2020; 192: E295-E301
• 16 Raff H, Sharma ST, Nieman LK. Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushingʼs syndrome, adrenal insufficiency, and congenital adrenal hyperplasia. Compr Physiol 2014; 4: 739-769
• 17 Hayashi T, Zhang Z, Al-Eyd G. et al. Expression of aldosterone synthase CYP11B2 was inversely correlated with longevity. J Steroid Biochem Mol Biol 2019; 191: 105361
• 18 Omata K, Anand SK, Hovelson DH. et al. Aldosterone-producing cell clusters frequently harbor somatic mutations and accumulate with age in normal adrenals. J Endocr Soc 2017; 1: 787-799
• 19 Shironomae T, Yamazaki Y, Takeyama J. et al. Development of aldosterone biosynthesis during fetal and pediatric periods; Histological analysis of CYP11B2-positive cell distribution in the zona glomerulosa of human adrenal. J Steroid Biochem Mol Biol 2024; 244: 106593
• 20 van de Wiel E, Chaman Baz AH, Kusters B. et al. Changes of the CYP11B2 expressing zona glomerulosa in human adrenals from birth to 40 years of age. Hypertension 2022; 79: 2565-2572
• 21 Allan F, Watson AH, Syme HM. Immunohistochemical expression of CYP11A1, CYP11B, CYP17, and HSD3B2 in functional and nonfunctional canine adrenocortical tumors. J Vet Intern Med 2024; 38: 3070-3078
• 22 Enberg U, Hennings J, Volpe C. et al. Increased ratio of mRNA expression of the genes CYP17 and CYP11B1 indicates autonomous cortisol production in adrenocortical tumors. J Endocrinol Invest 2009; 32: 810-815
• 23 Ono Y, Yamazaki Y, Omata K. et al. Histological characterization of aldosterone-producing adrenocortical adenomas with different somatic mutations. J Clin Endocrinol Metab 2020; 105: e282-e289
• 24 Bhatt MR, Khatri Y, Rodgers RJ, Martin LL. Role of cytochrome b5 in the modulation of the enzymatic activities of cytochrome P450 17alpha-hydroxylase/17,20-lyase (P450 17A1). J Steroid Biochem Mol Biol 2017; 170: 2-18
• 25 Gomez-Sanchez CE, Kuppusamy M, Reincke M, Williams TA. Disordered CYP11B2 expression in primary aldosteronism. Horm Metab Res 2017; 49: 957-962
• 26 Enberg U, Volpe C, Hoog A. et al. Postoperative differentiation between unilateral adrenal adenoma and bilateral adrenal hyperplasia in primary aldosteronism by mRNA expression of the gene CYP11B2. Eur J Endocrinol 2004; 151: 73-85